CLOV
NASDAQ · Health Care
Clover Health Investments Co
$1.89
+0.00 (+0.00%)
Financial Highlights (FY 2026)
Revenue
1.47B
Net Income
-46,249,656
Gross Margin
—
Profit Margin
-3.1%
Rev Growth
-2.3%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | — | 38.2% | 38.2% |
| Operating Margin | -3.3% | -3.0% | 22.2% | 21.5% |
| Profit Margin | -3.1% | -3.0% | 17.0% | 15.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.47B | 1.51B | 264.97M | 231.04M |
| Gross Profit | — | — | 101.34M | 88.36M |
| Operating Income | -49,229,303 | -45,367,983 | 58.88M | 49.62M |
| Net Income | -46,249,656 | -42,622,046 | 45.14M | 34.96M |
| Gross Margin | — | — | 38.2% | 38.2% |
| Operating Margin | -3.3% | -3.0% | 22.2% | 21.5% |
| Profit Margin | -3.1% | -3.0% | 17.0% | 15.1% |
| Rev Growth | -2.3% | -2.3% | -4.7% | +0.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 233.18M | 276.16M |
| Total Equity | — | — | 675.38M | 742.87M |
| D/E Ratio | — | — | 0.35 | 0.37 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -47,777,264 | -46,475,937 | 76.57M | 66.07M |
| Free Cash Flow | — | — | 32.12M | 25.98M |